These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9059729)

  • 1. Soluble CD30 levels in plasma and cerebrospinal fluid in multiple sclerosis, HIV infection and other nervous system diseases.
    Navikas V; Martin C; Matusevicius D; Söderström M; Fredrikson S; Link H
    Acta Neurol Scand; 1997 Feb; 95(2):99-102. PubMed ID: 9059729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum and CSF levels of soluble CD30 during clinical remission in multiple sclerosis.
    McMillan SA; McDonnell GV; Douglas JP; Droogan AG; Hawkins SA
    Neurology; 1998 Oct; 51(4):1156-60. PubMed ID: 9781547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of soluble CD30, tumour necrosis factor (TNF)-alpha and TNF receptors during primary HIV-1 infection: correlation with HIV-1 RNA and the clinical outcome.
    Rizzardi GP; Barcellini W; Tambussi G; Lillo F; Malnati M; Perrin L; Lazzarin A
    AIDS; 1996 Nov; 10(13):F45-50. PubMed ID: 8931778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS.
    Pizzolo G; Vinante F; Morosato L; Nadali G; Chilosi M; Gandini G; Sinicco A; Raiteri R; Semenzato G; Stein H
    AIDS; 1994 Jun; 8(6):741-5. PubMed ID: 8086130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1.
    Peluso MJ; Thanh C; Prator CA; Hogan LE; Arechiga VM; Stephenson S; Norris PJ; Di Germanio C; Fuchs D; Zetterberg H; Deeks SG; Gisslén M; Price RW; Henrich TJ
    J Virus Erad; 2020 Feb; 6(1):19-26. PubMed ID: 32175087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergen-induced CD30 expression on T cells of atopic asthmatics.
    Leonard C; Tormey V; Faul J; Burke CM; Poulter LW
    Clin Exp Allergy; 1997 Jul; 27(7):780-6. PubMed ID: 9249270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short communication: decreasing soluble CD30 and increasing IFN-gamma plasma levels are indicators of effective highly active antiretroviral therapy.
    Sadeghi M; Süsal C; Daniel V; Naujokat C; Zimmermann R; Huth-Kühne A; Opelz G
    AIDS Res Hum Retroviruses; 2007 Jul; 23(7):886-90. PubMed ID: 17678471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD30 and type 2 T helper (Th2) responses.
    Romagnani S; Del Prete G; Maggi E; Chilosi M; Caligaris-Cappio F; Pizzolo G
    J Leukoc Biol; 1995 May; 57(5):726-30. PubMed ID: 7759952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy.
    Keane NM; Price P; Lee S; Stone SF; French MA
    Clin Exp Immunol; 2001 Oct; 126(1):111-6. PubMed ID: 11678906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
    Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
    Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD).
    Bengtsson A; Holm L; Bäck O; Fransson J; Scheynius A
    Clin Exp Immunol; 1997 Sep; 109(3):533-7. PubMed ID: 9328133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies.
    Kusanovic JP; Romero R; Hassan SS; Gotsch F; Edwin S; Chaiworapongsa T; Erez O; Mittal P; Mazaki-Tovi S; Soto E; Than NG; Friel LA; Yoon BH; Espinoza J
    J Matern Fetal Neonatal Med; 2007 Dec; 20(12):867-78. PubMed ID: 17853188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum soluble CD30 is increased in pregnancies complicated with acute pyelonephritis.
    Kusanovic JP; Romero R; Esoinoza J; Gotsch F; Edwin S; Chaiworapongsa T; Mittal P; Soto E; Erez O; Mazaki-Tovi S; Than NG; Friel LA; Yoon BH; Mazor M; Hassan SS
    J Matern Fetal Neonatal Med; 2007 Nov; 20(11):803-11. PubMed ID: 17853184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis.
    Wang G; Hansen H; Tatsis E; Csernok E; Lemke H; Gross WL
    Am J Med; 1997 Jun; 102(6):517-23. PubMed ID: 9217665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High serum level of soluble CD30 in acute primary HIV-1 infection.
    Pizzolo G; Vinante F; Nadali G; Krampera M; Morosato L; Chilosi M; Raiteri R; Sinicco A
    Clin Exp Immunol; 1997 May; 108(2):251-3. PubMed ID: 9158093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Th1/Th2 cytokine balance and nitric oxide in cerebrospinal fluid and serum from patients with multiple sclerosis.
    Rodríguez-Sáinz Mdel C; Sánchez-Ramón S; de Andrés C; Rodríguez-Mahou M; Muñoz-Fernández MA
    Eur Cytokine Netw; 2002; 13(1):110-4. PubMed ID: 11956029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune surveillance in multiple sclerosis patients treated with natalizumab.
    Stüve O; Marra CM; Jerome KR; Cook L; Cravens PD; Cepok S; Frohman EM; Phillips JT; Arendt G; Hemmer B; Monson NL; Racke MK
    Ann Neurol; 2006 May; 59(5):743-7. PubMed ID: 16634029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of soluble CD30 are increased in children with chronic renal failure and with primary growth deficiency and decrease during treatment with recombination human growth hormone.
    Barbano G; Cappa F; Prigione I; Pistoia V; Cohen A; Chiesa S; Gusmano R; Perfumo F
    Nephrol Dial Transplant; 2001 Sep; 16(9):1807-13. PubMed ID: 11522862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of soluble CD30 in chronic hepatitis B virus infection.
    Fattovich G; Vinante F; Giustina G; Morosato L; Alberti A; Ruol A; Pizzolo G
    Clin Exp Immunol; 1996 Jan; 103(1):105-10. PubMed ID: 8565268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.